Neurotrophic factors in prostate and prostatic cancer

Prostate Cancer and Prostatic Diseases

Volumn 1, Issue 5, 1998, Pages 236-241

  Geldof, A A ^a   Van Haarst, E P ^a   Newling, D W W ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CNTF; GDNF; Nerve growth factor; Neurotrophic factors; NGF

Indexed keywords

EID: 0000472633     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500247     Document Type: Article

References (65)

1. Levi-Montalcini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool 1951; 116: 321-362.
2. Cohen S, Levi-Montalcini R, Hamburger V. A nerve growth stimulating factor isolated from sarcomas 37 and 180. Proc Natl Acad Sci USA 1954; 40: 1014-1018.
3. Ebendal T. Function and evolution in the NGF family and its receptors. J Neurosci Res 1992; 32: 461-470.
4. Lin L-FH et al. GDNF: a glial cell line derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993; 260: 1130-1132.
5. Purves D. The trophic theory of neural connections. Trends Neurosci 1986; 9: 486-489.
6. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991; 14: 453-501.
7. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237: 1154-1162.
8. Korsching S. The neurotrophic factor concept: a reexamination. J Neurosci 1993; 13: 2739-2748.
9. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996; 19: 289-317.
10. Levi-Montalcini R et al. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 1996; 19: 514-520.
11. Ebadi M et al. Neutrophins and their receptors in nerve injury and repair. Neurochemistry Int 1997; 30: 347-374.
12. Rogers BC. Development of recombinant human nerve growth factor (rhNGF) as a treatment for peripheral neuropathic disease. Neurotoxicology 1996; 17: 865-870.
13. Hefti F. Pharmacology of neurotrophic factors. Annu Rev Pharmacol Toxicol 1997; 37: 239-267.
14. Nakagawara A et al. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 1993; 328: 847-854.
15. Ehrhard PB et al. Expression of low-affinity NGF receptor and trkB mRNA in human SH-SY5Y neuroblastoma cells. FEBS Lett 1993; 330: 287-292.
16. Hamel W et al. Neurotrophin gene expression by cell lines derived from human gliomas. J Neurosci Res 1993; 34: 147-157.
17. Keles GE, Berger MS, Schofield D, Bothwell M. Nerve growth factor receptor expression in medulloblastomas and the potential role of nerve growth factor as a differentiating agent in medulloblastoma cell lines. Neurosurgery 1993; 32: 274-280.
18. Kim KH. A role of retinoic acid in the regulation of the morphology and the levels of intermediate filament proteins and mRNAs in PC12 cells. Exp Cell Res 1992; 203: 374-382.
19. Missale C et al. Nerve growth factor suppresses the transforming pheno-type of human prolactinomas. Proc Natl Acad Sci USA 1993; 90: 7961-7965.
20. Ladenheim RG et al. Endothelins stimulate c-fos and nerve growth factor expression in astrocytes and astrocytoma. J Neurochem 1993; 60: 260-266.
21. Hertel C, Schubenel R. Nerve growth factor-induced loss of cell-associated nerve growth factor receptor in human melanoma A875 cells. Neurosci Lett 1992; 136: 113-117.
22. Polak M et al. Nerve growth factor induces neuronlike differentiation of an insulin-secreting pancreatic beta cell line. Proc Natl Acad Sci USA 1993; 90: 5781-5785.
23. Marchetti D et al. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int J Cancer 1993; 55: 692-699.
24. Herrmann JL et al. Mediation of ngf-stimulated extracellular invasion by the human melanoma low-affinity P75 neurotrophin receptor-Melanoma P75 functions independently of Trka. Mol Biol Cell 1993; 4: 1205-1216.
25. Engebraaten O, Bjerkvig R, Pedersen PH, Laerum OD. Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human braintumour biopsies in vitro. Int J Cancer 1993; 53: 209-214.
26. Nicolson GL et al. Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors. J Neurooncol 1993; 18: 139-149.
27. Harper GP et al. Guinea pig prostate is a rich source of nerve growth factor. Nature 1979; 279: 160-162.
28. Schwartz MA, Fisher D, Bradshaw RA, Isackson PJ. Isolation and sequence of a cDNA clone of beta-nerve growth factor from the guinea pig prostafe gland. J Neurochem 1989; 52: 1203-1209.
29. DeSchryver-Kecskemeti K, Balogh K, Neet E. Nerve growth factor and the concept of neural-epithelial interactions. Arch Pathol Lab Med 1987; 111: 833-835.
30. Djakiew D et al. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate. Cancer Res 1991; 51: 3304-3310.
31. Djakiew D. Role of nerve growth factor-like protein in the paracrine regulation of prostate growth. J Androl 1992; 13: 476-487.
32. Djakiew D, Pflug B, Onoda M. Stromal-epithelial paracrine interactions in the neoplastic rat and human prostate. Adv Exp Med Biol 1993a; 330: 185-202.
33. Graham CW, Lynch JH, Djakiew D. Distribution of nerve growth factorlike protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma. J Urol 1992; 147: 1444-1447.
34. MacGrogan D, Saint-André J-P, Dicou E. Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines. J Neurochem 1992; 59: 1381-1391.
35. Paul AB, Grant ES, Habib FK. The expression and localisation of β-nerve growth factor (β-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation. Br J Cancer 1996; 74: 1990-1996.
36. Harper GP, Thoenen H. Tine distribution of nerve growth factor in the male sex organs of mammals. J Neurochem 1980; 34: 893-903.
37. Shikata H et al. Immunohistochemical localization of nerve growth factor and epidermal growth factor in guinea pig prostate gland. Histochem J 1984; 80: 411-413.
38. MacGrogan D, Després G, Romand R, Dicou E. Expression of the β-nerve growth factor gene in male sex organs of the mouse, rat and guinea pig. J Neurosci Res 1990; 28: 567-573.
39. di Sant' Agnese PA. Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol 1992; 23: 287-296.
40. di Sant' Agnese PA. Neuroendocrine differentiation in prostatic carcinoma: recent findings and new concepts. Cancer 1995; 75 (suppl): 1850-1859.
41. Pflug BR, Onoda M, Lynch JH, Djakiew D. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res 1992; 52: 5403-5406.
42. Perez M et al. Loss of low-affinity nerve growth factor receptor during malignant transformation of the human prostate. Prostate 1997; 30: 274-279.
43. Pflug BR et al. Expression of a Trk high affinity nerve growth factor receptor in the human prostate. Endocrinology 1995; 136: 262-268.
44. Rabizadeh S et al. Induction of apoptosis by the low-affinity NGF receptor. Science 1993; 261: 345-348.
45. Djakiew D, Delsite D, Dalal R, Pflug B. The role of the low affinity nerve growth factor receptor and the high affinity Trk receptor in human prostate carcinogenesis. Radiat Oncol Invest 1996; 3: 333-339.
46. Chung LWK et al. Human prostate cancer model: roles of growth factors and extracellular matrices. J Cell Biochem 1992; 16H (suppl): 99-105.
47. Djakiew D et al. Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res 1993b; 53: 1416-1420.
48. Geldof AA, De Kleijn MAT, Rao BR, Newling DWW. Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells. J Cancer Res Clin Oncol 1997; 123: 107-112.
49. Cunha GR. Growth factors as mediators of androgen action during male urogenital development. Prostate 1996; 6 (suppl): 22-25.
50. McVary KT et al. Growth of the prostate gland is facilitated by the autonomic nervous system. Biol Reprod 1994; 51: 99-107.
51. Lepor H, Shapiro E, Bowsher RR, Hery DP. Determination of norepinephrine levels in the adult human prostate. J Urol 1990; 144: 1263-1266.
52. Villers A et al. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 1989; 142: 763-768.
53. Bastacky SI, Walsh PC, Epstein Jl. Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol 1993; 17:336-341.
54. Rodin AE, Larson DL, Roberts DK. Nature of the perineural space invaded by prostatic carcinoma. Cancer 1967; 20: 1772-1779.
55. Miknyoczki SJ, Kleinszanto AJP, Ruggeri BA. Neurotrophin-Trk receptor interactions in neoplasia - a possible role in interstitial and perineural invasion in ductal pancreatic cancer. Crit Rev Oncogen 1996; 7: 89-100.
56. Geldof AA, Rao BR. Prostatic tumor (R3327) skeletal metastasis. Prostate 1990; 16: 270-290.
57. Katohsemba et al. Regulation by androgen of levels of the beta subunit of nerve growth factor and its mRNA in selected regions of the mouse brain. J Neurochem 1994; 62: 2141-2147.
58. Lonnerberg et al. β-Nerve growth factor influences the expression of androgen-binding protein messenger ribonucleic acid in the rat testis. Biol Reprod 1992; 47: 381-388.
59. Rajah et al. Insulin-like growth factor binding protein (IGFBP) proteases: functional regulators of cell growth. Progr Growth Factor Res 1995; 6: 273-284.
60. Rajah et al. 7S Nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology 1996; 137: 2676-2682.
61. Day ML, Wu S, Basler JW. Prostate nerve growth factor inducible A gene binds a novel element in the retinoblastoma gene promoter. Cancer Res 1993; 53: 5597-5599.
62. Day ML et al. Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells. Cell Growth Diff 1994; 5: 735-741.
63. Dalal R, Djakiew D. Molecular characterization of neurotrophin expression and the receptor kinases (trks) in epithelial and stromal cells of the human prostate. Molec Cell Endocrinol 1997; 134: 15-22.
64. Nitta A et al. Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats. Eur J Pharmacol 1993; 250: 23-30.
65. Delsite R, Djakiew D. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines. J Androl 1996; 17: 481-490.